Colgate CEO Sells Billions in Shares Right After Earnings Announcement

Colgate-Palmolive Company (NYSE: CL) reported its fourth-quarter and full-year 2025 results on January 30, noting that a noncash impairment charge of approximately $794 million related to its skin-health business sharply reduced GAAP net income. Despite this, its business-basis earnings per share and operating cash flow improved, driving record cash flow of about $4.2 billion (KRW 5.46 trillion). In 2025, the company returned roughly $2.9 billion (KRW 3.8 trillion) to shareholders through dividends and share repurchases, and it forecast for 2026 net sales growth of 2–6%, organic sales growth of 1–4%, and double-digit GAAP EPS growth.

On February 4, Chairman and CEO Noel Wallace sold approximately $42.8 million (KRW 5.6 billion) of Colgate-Palmolive common stock in an open-market transaction. After this sale, his direct and indirect holdings were valued at about $378 million (KRW 49 billion) based on the recent share price.

Earlier, the fourth-quarter 2025 results announced on January 30 showed revenue of $5.23 billion and EPS of $0.95, exceeding market expectations. In early January, Morgan Stanley named Colgate-Palmolive its top pick in the household and personal products sector for 2026, anticipating a recovery in organic sales and earnings growth following a subdued 2025.

Headquartered in New York, Colgate-Palmolive is a global consumer-goods company with a broad product portfolio, including oral care items such as toothpaste and toothbrushes; personal hygiene products like soap and shampoo; laundry detergents and fabric softeners; and Hill’s pet nutrition brands. The household and personal products industry, as a provider of essential consumer goods, typically sees stable demand that is less sensitive to economic cycles, with brand strength, global distribution networks, and emerging-market growth identified as key competitive factors.